
Evaluating Pharma AI Consulting Firms: 2026 Framework
A 2026 evaluation framework for selecting pharma AI consulting firms. Review vendor criteria including regulatory compliance, data governance, and AI expertise.

A 2026 evaluation framework for selecting pharma AI consulting firms. Review vendor criteria including regulatory compliance, data governance, and AI expertise.

A proven framework for CDMO selection in pharma and biotech, with scorecards, due diligence checklists, and governance KPIs — updated April 2026 with BIOSECURE Act, Catalent/Novo deal, and EU GMP Annex 1 impacts.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, vendor evaluation criteria, and the emerging foundation model licensing trend. Updated April 2026 with EU AI Act compliance deadlines, FDA-EMA joint guidance, and latest pharma AI partnerships.
© 2026 IntuitionLabs. All rights reserved.